These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9201796)

  • 1. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.
    Hege SG; Ellinwood EH; Wilson WH; Helligers CA; Graham SM
    Psychopharmacology (Berl); 1997 May; 131(2):101-7. PubMed ID: 9201796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.
    Duka T; Schütt B; Krause W; Dorow R; McDonald S; Fichte K
    Br J Clin Pharmacol; 1993 Apr; 35(4):386-94. PubMed ID: 8097921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.
    O'Neill WM; Hanks GW; Simpson P; Fallon MT; Jenkins E; Wesnes K
    Pain; 2000 Mar; 85(1-2):209-15. PubMed ID: 10692620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects.
    Hanks GW; O'Neill WM; Simpson P; Wesnes K
    Eur J Clin Pharmacol; 1995; 48(6):455-60. PubMed ID: 8582463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.
    Stephens DN; Schneider HH; Kehr W; Andrews JS; Rettig KJ; Turski L; Schmiechen R; Turner JD; Jensen LH; Petersen EN
    J Pharmacol Exp Ther; 1990 Apr; 253(1):334-43. PubMed ID: 1970361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects.
    O'Neill WM; Hanks GW; White L; Simpson P; Wesnes K
    Eur J Clin Pharmacol; 1995; 48(6):447-53. PubMed ID: 8582462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-dissociation of behavioural and event-related potential effects of two benzodiazepines with similar potencies.
    Pompéia S; Bueno OF; Lucchesi LM; Manzano GM; Galduróz JC; Tufik S
    J Psychopharmacol; 2000; 14(3):288-98. PubMed ID: 11106311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etifoxine impairs neither alertness nor cognitive functions of the elderly: A randomized, double-blind, placebo-controlled crossover study.
    Deplanque D; Machuron F; Waucquier N; Jozefowicz E; Duhem S; Somers S; Colin O; Duhamel A; Bordet R
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):925-932. PubMed ID: 30135030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single oral doses of clobazam, diazepam and lorazepam on performance tasks and memory.
    Patat A; Klein MJ; Hucher M
    Eur J Clin Pharmacol; 1987; 32(5):461-6. PubMed ID: 2887431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
    Lister RG; File SE
    J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance.
    Dawson J; Boyle J; Stanley N; Johnsen S; Hindmarch I; Skene DJ
    Hum Psychopharmacol; 2008 Oct; 23(7):605-13. PubMed ID: 18570226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers.
    Ferrara SD; Giorgetti R; Zancaner S; Orlando R; Tagliabracci A; Cavarzeran F; Palatini P
    Eur J Clin Pharmacol; 1999 Jan; 54(11):821-7. PubMed ID: 10027654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.